行情

AMAG

AMAG

Amag制药
NASDAQ

实时行情|Nasdaq Last Sale

9.93
+0.10
+1.02%
交易中 15:04 11/21 EST
开盘
9.83
昨收
9.83
最高
10.13
最低
9.74
成交量
37.58万
成交额
--
52周最高
19.44
52周最低
6.81
市值
3.37亿
市盈率(TTM)
-1.1803
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AMAG 新闻

  • Teva, Bausch Could Be Next to File for Bankruptcy
  • GuruFocus.com.1天前
  • SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG
  • ACCESSWIRE.5天前
  • SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG
  • GlobeNewswire.11/13 19:14
  • AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
  • GlobeNewswire.11/13 13:00

更多

所属板块

制药
+0.48%
制药与医学研究
+0.27%

热门股票

名称
价格
涨跌幅

AMAG 简况

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.
展开

Webull提供AMAG Pharmaceuticals, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。